Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119238889> ?p ?o ?g. }
- W2119238889 endingPage "19" @default.
- W2119238889 startingPage "1" @default.
- W2119238889 abstract "Hepatitis C virus (HCV) is a blood-borne virus estimated to infect around 170 million people worldwide and is, therefore, a major disease burden. In some individuals the virus is spontaneously cleared during the acute phase of infection, whilst in others a persistent infection ensues. Of those persistently infected, severe liver diseases such as cirrhosis and primary liver cancer may develop, although many individuals remain asymptomatic. A range of factors shape the course of HCV infection, not least host genetic polymorphisms and host immunity. A number of studies have shown that neutralizing antibodies (nAb) arise during HCV infection, but that these antibodies differ in their breadth and mechanism of neutralization. Recent studies, using both mAbs and polyclonal sera, have provided an insight into neutralizing determinants and the likely protective role of antibodies during infection. This understanding has helped to shape our knowledge of the overall structure of the HCV envelope glycoproteins – the natural target for nAb. Most nAb identified to date target receptor-binding sites within the envelope glycoprotein E2. However, there is some evidence that other viral epitopes may be targets for antibody neutralization, suggesting the need to broaden the search for neutralization epitopes beyond E2. This review provides a comprehensive overview of our current understanding of the role played by nAb in HCV infection and disease outcome and explores the limitations in the study systems currently used. In addition, we briefly discuss the potential therapeutic benefits of nAb and efforts to develop nAb-based therapies." @default.
- W2119238889 created "2016-06-24" @default.
- W2119238889 creator A5001910378 @default.
- W2119238889 creator A5027895154 @default.
- W2119238889 creator A5031700609 @default.
- W2119238889 creator A5081606290 @default.
- W2119238889 date "2012-01-01" @default.
- W2119238889 modified "2023-10-18" @default.
- W2119238889 title "The role of neutralizing antibodies in hepatitis C virus infection" @default.
- W2119238889 cites W1512482605 @default.
- W2119238889 cites W1535549793 @default.
- W2119238889 cites W1635062911 @default.
- W2119238889 cites W1842798465 @default.
- W2119238889 cites W1843544875 @default.
- W2119238889 cites W1871241548 @default.
- W2119238889 cites W1882904690 @default.
- W2119238889 cites W1921694076 @default.
- W2119238889 cites W1960802388 @default.
- W2119238889 cites W1963707175 @default.
- W2119238889 cites W1963755147 @default.
- W2119238889 cites W1964573817 @default.
- W2119238889 cites W1967491261 @default.
- W2119238889 cites W1969654131 @default.
- W2119238889 cites W1975976410 @default.
- W2119238889 cites W1976569781 @default.
- W2119238889 cites W1976950601 @default.
- W2119238889 cites W1977889013 @default.
- W2119238889 cites W1979003966 @default.
- W2119238889 cites W1981136135 @default.
- W2119238889 cites W1985680307 @default.
- W2119238889 cites W1986498353 @default.
- W2119238889 cites W1986551392 @default.
- W2119238889 cites W1987173750 @default.
- W2119238889 cites W1993690048 @default.
- W2119238889 cites W1996295206 @default.
- W2119238889 cites W1997677784 @default.
- W2119238889 cites W1997677874 @default.
- W2119238889 cites W1999490244 @default.
- W2119238889 cites W2000835793 @default.
- W2119238889 cites W2002451924 @default.
- W2119238889 cites W2003579943 @default.
- W2119238889 cites W2004651002 @default.
- W2119238889 cites W2006538744 @default.
- W2119238889 cites W2007106596 @default.
- W2119238889 cites W2008860633 @default.
- W2119238889 cites W2009108547 @default.
- W2119238889 cites W2009911047 @default.
- W2119238889 cites W2012420380 @default.
- W2119238889 cites W2014742624 @default.
- W2119238889 cites W2015489330 @default.
- W2119238889 cites W2015723482 @default.
- W2119238889 cites W2015878390 @default.
- W2119238889 cites W2017359325 @default.
- W2119238889 cites W2021900004 @default.
- W2119238889 cites W2022077416 @default.
- W2119238889 cites W2023645777 @default.
- W2119238889 cites W2027569651 @default.
- W2119238889 cites W2030371794 @default.
- W2119238889 cites W2034501752 @default.
- W2119238889 cites W2034996626 @default.
- W2119238889 cites W2035508195 @default.
- W2119238889 cites W2042994480 @default.
- W2119238889 cites W2043907643 @default.
- W2119238889 cites W2047619471 @default.
- W2119238889 cites W2048974214 @default.
- W2119238889 cites W2049107903 @default.
- W2119238889 cites W2050502453 @default.
- W2119238889 cites W2053536599 @default.
- W2119238889 cites W2055822853 @default.
- W2119238889 cites W2056374390 @default.
- W2119238889 cites W2056548406 @default.
- W2119238889 cites W2058115636 @default.
- W2119238889 cites W2063495032 @default.
- W2119238889 cites W2063673733 @default.
- W2119238889 cites W2064546869 @default.
- W2119238889 cites W2066705292 @default.
- W2119238889 cites W2067107443 @default.
- W2119238889 cites W2072187355 @default.
- W2119238889 cites W2075147482 @default.
- W2119238889 cites W2075864449 @default.
- W2119238889 cites W2077827918 @default.
- W2119238889 cites W2077980485 @default.
- W2119238889 cites W2083579867 @default.
- W2119238889 cites W2086564022 @default.
- W2119238889 cites W2086853864 @default.
- W2119238889 cites W2089866845 @default.
- W2119238889 cites W2090297731 @default.
- W2119238889 cites W2092637586 @default.
- W2119238889 cites W2094254049 @default.
- W2119238889 cites W2099046838 @default.
- W2119238889 cites W2099459835 @default.
- W2119238889 cites W2100752714 @default.
- W2119238889 cites W2102227311 @default.
- W2119238889 cites W2106399441 @default.
- W2119238889 cites W2107095788 @default.
- W2119238889 cites W2108463852 @default.
- W2119238889 cites W2109124959 @default.
- W2119238889 cites W2109514681 @default.